KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Capital Employed: 2019-2025

Historic Return on Capital Employed for Castle Biosciences (CSTL) over the last 6 years, with Sep 2025 value amounting to -0.07%.

  • Castle Biosciences' Return on Capital Employed fell 7.00% to -0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.07%, marking a year-over-year decrease of 7.00%. This contributed to the annual value of 0.02% for FY2024, which is 19.00% up from last year.
  • Latest data reveals that Castle Biosciences reported Return on Capital Employed of -0.07% as of Q3 2025, which was down 43.61% from -0.05% recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Return on Capital Employed registered a high of 0.02% during Q4 2024, and its lowest value of -0.25% during Q2 2023.
  • Moreover, its 3-year median value for Return on Capital Employed was -0.07% (2025), whereas its average is -0.10%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first decreased by 12bps in 2022, then rose by 21bps in 2024.
  • Castle Biosciences' Return on Capital Employed (Quarterly) stood at -0.09% in 2021, then dropped by 8bps to -0.17% in 2022, then remained steady at -0.17% in 2023, then climbed by 19bps to 0.02% in 2024, then decreased by 7bps to -0.07% in 2025.
  • Its Return on Capital Employed was -0.07% in Q3 2025, compared to -0.05% in Q2 2025 and -0.03% in Q1 2025.